2001 National Drug Strategy Household Survey: detailed findings

2001 National Drug Strategy Household Survey: detailed findings

FREE

Phone, fax or email orders:

Department of Health and Ageing
Tel. 1800 020103 x 8654
Fax 02 6289 8360
Email

Read the related media release.

View other publications in the same series: Drug statistics series.

View other publications by the same author: AIHW.

View other publications in the same subject area: Alcohol and other drugs.

Drug statistics series no. 11

This report extends the statistical analysis of the 2001 National Drug Strategy Household Survey presented in 2001 National Drug Strategy Household Survey: first results. It provides comprehensive information on tobacco, alcohol and illicit drug use patterns, community perceptions of drug use, support for drug-related policy and legislation, and drug use among special population groups. This report, along with others in the Drug statistics series, will be a useful resource for policy makers, planners and researchers interested in drug-related matters.

Authored by AIHW.

Published 19 December 2002; ISSN 1442-7230; ISBN-13 978 1 74024 233 2; AIHW cat. no. PHE 41; 141pp.; FREE

This publication is only available from the Department of Health and Ageing. See below left for ordering information.

Download free

Help with downloads

Full publication

Publication table of contents

  • Preliminary material (212K PDF)
    • Title and verso pages
    • Preface
    • Contents
    • List of tables
    • List of figures
    • Summary
    • Acknowledgments
    • Abbreviations
  • Sections

    1. Introduction (92K PDF)

      • The National Drug Strategy
      • About the 2001 survey
      • Comparison with previous surveys
      • Comparison with the 2001 National Health Survey
    2. Perceptions and acceptability of drug use (161K PDF)
      • Introduction
      • Drugs perceived to be associated with a 'drug problem' 
      • Form of drug use perceived to be of most serious concern for the general community
      • Drugs perceived to be associated with mortality
      • Approval of drug use
      • Perceptions of health effects of alcohol use
      • Perceptions of health effects of tobacco use
    3. Availability of drugs (121K PDF)
      • Offer or opportunity to use drugs
      • Acceptance of the offer or opportunity to use drugs
      • Ease of obtaining illicit drugs
    4. Use of tobacco (146K PDF)
      • Introduction
      • Tobacco smoking status
      • Type of tobacco smoked
      • Unbranded loose tobacco
      • Changes to smoking behaviour
      • Motivations for change to behaviour
      • Characteristics by smoking status
    5. Use of alcohol (155K PDF)
      • Introduction
      • Alcohol consumption risk status
      • Type of alcohol consumed
      • Usual place of use of alcohol
      • Moderating drinking behaviour
      • Alcohol-induced memory lapse
      • Alcohol reduction
      • Characteristics by alcohol risk status
    6. Illicit drug use (141K PDF)
      • Introduction
      • Use of any illicit drug
      • Use of any illicit drug except marijuana/cannabis
      • Non-users of illicit drugs
    7. Marijuana/cannabis (128K PDF)
      • Introduction
      • Use of marijuana/cannabis
      • Frequency of use of marijuana/cannabis
      • Form, quantity and method of use of marijuana/cannabis
      • Source of supply of marijuana/cannabis
      • Usual place of use of marijuana/cannabis
      • Concurrent drug use with marijuana/cannabis
      • Substitution of other drugs for marijuana/cannabis
    8. Prescription drugs (used for non-medical purposes) (120K PDF)
      • Introduction
      • Use of prescription drugs for non-medical purposes
      • Recent use of selected prescription drugs for non-medical purposes
      • Frequency of use of prescription drugs for non-medical purposes
      • Source of supply of prescription drugs for non-medical purposes
      • Usual place of use of prescription drugs for non-medical purposes
      • Concurrent drug use with prescription drugs used for non-medical purposes
      • Substitution of other drugs for prescription drugs used for non-medical purposes
    9. Hallucinogens (127K PDF)
      • Introduction
      • Use of hallucinogens
      • Frequency of use of hallucinogens
      • Form and quantity of hallucinogens used
      • Source of supply of hallucinogens
      • Usual place of use of hallucinogens
      • Concurrent drug use with hallucinogens
      • Substitution of other drugs for hallucinogens
      • Hallucinogens use by friends and acquaintances
    10. Heroin, methadone and other opiates (117K PDF)
      • Introduction
      • Use of heroin, methadone and/or other opiates
      • Frequency of use of heroin, methadone and/or other opiates
      • Form and quantity of heroin, methadone and other opiates used
      • Method of use of heroin, methadone and other opiates
      • Source of supply of heroin and methadone
      • Usual place of use of heroin and methadone
      • Concurrent drug use with heroin, methadone and other opiates
      • Substitution of other drugs for heroin and methadone

    11. Amphetamines (125K PDF)

      • Introduction
      • Use of amphetamines
      • Frequency of use of amphetamines
      • Form and quantity of amphetamines used
      • Source of supply of amphetamines
      • Usual place of use of amphetamines
      • Concurrent drug use with amphetamines
      • Substitution of other drugs for amphetamines
      • Amphetamines use by friends and acquaintances
    12. Ecstasy/designer drugs (124K PDF)
      • Introduction
      • Use of ecstasy/designer drugs
      • Frequency of use of ecstasy/designer drugs
      • Source of supply and quantity used of ecstasy/designer drugs
      • Usual place of use of ecstasy/designer drugs
      • Concurrent drug use with ecstasy/designer drugs
      • Substitution of other drugs for ecstasy/designer drugs
      • Ecstasy/designer drugs use by friends and acquaintances
    13. Cocaine (124K PDF)
      • Introduction
      • Use of cocaine
      • Frequency of use of cocaine
      • Form, quantity and method of use of cocaine
      • Source of supply of cocaine
      • Usual place of use of cocaine
      • Concurrent drug use with cocaine
      • Substitution of other drugs for cocaine
      • Cocaine use by friends and acquaintances
    14. Inhalants (124K PDF)
      • Introduction
      • Use of inhalants
      • Frequency of use of inhalants
      • Source of supply and quantity of inhalants used
      • Usual place of use of inhalants
      • Concurrent drug use with inhalants
      • Substitution of other drugs for inhalants
      • Inhalants use by friends and acquaintances
    15. Injecting drugs (used for non-medical purposes) (114K PDF)
      • Introduction
      • Lifetime and recent injecting drug use
      • Frequency of injecting drug use
      • Source of supply and re-use of needles and syringes
    16. Drug-related incidents and potential harm (133K PDF)
      • Introduction
      • Drug-related incidents
      • Potential for drug-related harm
    17. Drug-related policy (120K PDF)
      • Support for policy measures
      • Nominal distribution of a drugs budget
    18. Drug-related legislation (127K PDF)
      • Support for legalisation of illicit drugs
      • Support for increased penalties for the sale or supply of illicit drugs
      • Support for actions against those in possession of illicit drugs
      • Legalisation of marijuana
    19. Drugs and health (117K PDF)
      • Self-assessed health status
      • Use of someone else's prescribed medication
      • Environmental tobacco smoke
    20. Drugs and young people (125K PDF)
      • Introduction
      • Tobacco
      • Alcohol
      • Illicit drugs
    21. Special populations - summary tables of drug use (132K PDF)
  • End matter (149K PDF)
    • References
    • Appendixes
      1. Glossary
      2. Population estimates
      3. Standard errors
      4. Selected comparison of the NDSHS and the NHS
      5. Definition of characteristics variables

2001 National Drug Strategy Household Survey